GlassScriptPhysician profile
Fadi Aldaas
NPI 1417245499
$18,264.01
in general payments reported to CMS, 2019-2025
30 companies · $1,657 in 2025
The $1,657 reported for 2025 was more than what 84% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $87.39 · 2021: $226 · 2022: $1,157 · 2023: $5,079 · 2024: $9,563 · 2025: $1,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $11K · Food and Beverage: $5,282 · Travel and Lodging: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,655.47 |
| Food and Beverage | $5,282.40 |
| Travel and Lodging | $360.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,225.74 | 2023-2024 | Ion, Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $1,851.14 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,322.29 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Genzyme Corporation | $590.66 | 2022-2025 | |
| Grifols USA, LLC | $415.45 | 2022-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $383.00 | 2019-2025 | Ofev |
| Jazz Pharmaceuticals INC. | $333.08 | 2019-2025 | |
| Electromed, INC. | $294.12 | 2022-2025 | Smartvest |
| Insmed, INC. | $260.33 | 2024-2025 | Arikayce, Brinsupri |
| Olympus America INC. | $178.11 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $170.77 | 2022-2025 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $162.63 | 2019-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $158.67 | 2022-2024 | Glassia, Cuvitru |
| Sanofi-Aventis U.S. LLC | $155.47 | 2024-2025 | |
| Inogen, INC. | $152.65 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $93.78 | 2019-2022 | |
| Amgen INC. | $79.04 | 2022-2024 | Tezspire |
| Baxter Healthcare | $70.03 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Pulmonx Corporation | $62.37 | 2023 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Sunovion Pharmaceuticals INC. | $50.74 | 2019 | |
| Philips North America LLC | $45.30 | 2022-2023 | |
| Teva Pharmaceuticals USA, INC. | $39.34 | 2022 | |
| Merck Sharp & Dohme LLC | $35.65 | 2023 | Zerbaxa, Dificid |
| Novartis Pharmaceuticals Corporation | $24.78 | 2019 | |
| Abiomed | $23.93 | 2020 | |
| Inspire Medical Systems, INC. | $21.59 | 2025 | Inspire |
| Phadia US INC. | $16.35 | 2023 | Immunocap |
| E.R. Squibb & Sons, L.L.C. | $16.14 | 2022 | |
| Verona Pharma, INC. | $15.60 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $15.26 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fadi Aldaas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.